Page 536 - Williams Hematology ( PDFDrive )
P. 536

510  Part VI:  The Erythrocyte  Chapter 34:  Clinical Manifestations and Classification of Erythrocyte Disorders      511




                    32.  Pearson TC, Humphrey PRD, Thomas DJ, et al: Hematocrit, blood viscosity, cere-    40.  Lubarsky DA, Gallagher CJ, Berend JL: Secondary polycythemia does not increase the
                     bral blood flow, and vascular occlusion, in Clinical Aspects of Blood Viscosity and Cell   risk of perioperative hemorrhagic or thrombotic complications. J Clin Anesth 3(2):99,
                     Deformability, edited by GDO Lowe. Springer-Verlag, New York, 1981.  1991.
                    33.  Monge CM, Monge CC: High-Altitude Diseases: Mechanism and Management, Charles     41.  Thomas DJ, du Boulay GH, Marshall J, et al: Cerebral blood-flow in polycythaemia.
                     C Thomas, Springfield, IL, 1966.                      Lancet 2(8030):161, 1977.
                    34.  Kershenovich S, Modiano M, Ewy GA: Markedly decreased coronary blood flow in     42.  Friedrich CA: Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum
                     secondary polycythemia. Am Heart J 123(2):521, 1992.  Mol Genet 10(7):763, 2001.
                    35.  Conley CL, Russell RP, Thomas CB, et al: Hematocrit values in coronary artery disease.     43.  Gordeuk VR, Sergueeva AI, Miasnikova GY, et al: Congenital disorder of oxygen sens-
                     Arch Intern Med 113:170, 1964.                        ing: Association of the homozygous Chuvash polycythemia VHL mutation with throm-
                    36.  Kaushansky K: Thrombopoietin. N Engl J Med 339(11):746, 1998.  bosis and vascular abnormalities but not tumors. Blood 103:3924, 2004.
                    37.  Geddis AE, Kaushansky K: Cross-reactivity between erythropoietin and thrombopoie-    44.  Zhuang Z, Yang C, Lorenzo F, et al: Somatic HIF2A gain-of-function mutations in para-
                     tin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency.   ganglioma with polycythemia. N Engl J Med 367(10):922, 2012.
                     J Pediatr Hematol Oncol 25(11):919; author reply 920, 2003.    45.  Lorenzo FR, Yang C, Ng Tang et al: A novel EPAS1/HIF2A germline mutation in a
                    38.  Mayer GA: Hematocrit and coronary heart disease. Can Med Assoc J 93(22):1151, 1965.  congenital polycythemia with paraganglioma. J Mol Med (Berl) 91(4):507, 2013.
                    39.  Hershberg PI, Wells RE, McGandy RB: Hematocrit and prognosis in patients with acute
                     myocardial infarction. JAMA 219(7):855, 1972.











































































          Kaushansky_chapter 34_p0503-0512.indd   511                                                                   9/17/15   6:12 PM
   531   532   533   534   535   536   537   538   539   540   541